cefamandole has been researched along with Cholelithiasis* in 2 studies
1 trial(s) available for cefamandole and Cholelithiasis
| Article | Year |
|---|---|
Wound infection in elective biliary surgery: controlled trial using one dose cephamandole.
In a prospective randomized double-blind trial using a 1 g single dose of cephamandole versus placebo, given 1 h before surgery, the wound infection rate after elective surgery for gallbladder stones in 200 consecutive cases was 11%, being 15% in the placebo group and 7% in the cephamandole group (chi 2 = 4.03; P less than 0.05). The average hospital stay was 7.7 days in the absence of wound infection and 13.6 days in the presence of wound infection. Contaminated bile was significantly positively related to wound infection, and cephamandole significantly protected the culture-positive group from wound infection. Topics: Adult; Aged; Cefamandole; Cholelithiasis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Surgical Wound Infection | 1985 |
1 other study(ies) available for cefamandole and Cholelithiasis
| Article | Year |
|---|---|
Cefoxitin and cefamandole levels in the human bile.
The bile levels of cefoxitin and cefamandole were studied in 75 patients. The two antibiotics were shown to be present at high concentration and to undergo a rapid metabolization. It is concluded that they represent the antibiotics of choice in the prophylactic and therapeutic treatment of biliary tract infections. Topics: Bile; Bile Duct Diseases; Cefamandole; Cefoxitin; Cholelithiasis; Chromatography, High Pressure Liquid; Humans; Microbial Sensitivity Tests; Sarcina | 1985 |